Journal article
Investigation of FGFR2-IIIC Signaling via FGF-2 Ligand for Advancing GCT Stromal Cell Differentiation
Abstract
Giant cell tumor of bone (GCT) is an aggressive bone tumor consisting of multinucleated osteoclast-like giant cells and proliferating osteoblast-like stromal cells. The signaling mechanism involved in GCT stromal cell osteoblastic differentiation is not fully understood. Previous work in our lab reported that GCT stromal cells express high levels of TWIST1, a master transcription factor in skeletal development, which in turn down-regulates …
Authors
Singh S; Singh M; Mak IWY; Turcotte R; Ghert M
Journal
PLOS ONE, Vol. 7, No. 10,
Publisher
Public Library of Science (PLoS)
Publication Date
2012
DOI
10.1371/journal.pone.0046769
ISSN
1932-6203
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Antigens, DifferentiationBone NeoplasmsCalcification, PhysiologicCell DifferentiationCell ProliferationCell SurvivalCells, CulturedCore Binding Factor Alpha 1 SubunitExtracellular Signal-Regulated MAP KinasesFibroblast Growth Factor 2Gene ExpressionGene Knockdown TechniquesGiant Cell Tumor of BoneHumansMesenchymal Stem CellsNuclear ProteinsOsteogenesisPrimary Cell CultureProtein IsoformsRNA, Small InterferingReceptor, Fibroblast Growth Factor, Type 2Signal TransductionTwist-Related Protein 1